MedPath

Obese Patients With Type 2 Diabetes

Phase 3
Completed
Conditions
Obesity
Diabetes Mellitus, Non-Insulin-Dependent
Obesity in Diabetes
Registration Number
NCT00029848
Lead Sponsor
Sanofi
Brief Summary

To assess the effect on weight loss and weight maintenance over a period of one year when prescribed with a hypocaloric diet in obese patients with Type 2 Diabetes

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1045
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change in body weight
Secondary Outcome Measures
NameTimeMethod
Metabolic parameters

Trial Locations

Locations (43)

The Chase Wellness Center, Inc.

🇺🇸

Virginia Beach, Virginia, United States

Salem Veterans Affairs Medical Center (151)

🇺🇸

Salem, Virginia, United States

Kansas University Medical Center

🇺🇸

Kansas City, Kansas, United States

Twin Cities Clinical Research

🇺🇸

Arden Hills, Minnesota, United States

MFP Research, Inc.

🇺🇸

Cincinnati, Ohio, United States

University of Oklahoma Health Sciences Center

🇺🇸

Oklahoma City, Oklahoma, United States

Innovative Clinical Trials

🇺🇸

Birmingham, Alabama, United States

Southern California Prevention and Research Center Inc. (SPARC)

🇺🇸

Encino, California, United States

Advanced Clinicla Therapeutics, LLC

🇺🇸

Tucson, Arizona, United States

Diablo Clinical Research, Inc.

🇺🇸

Walnut Creek, California, United States

North East Clinical Research

🇺🇸

Hamden, Connecticut, United States

Clinical Research of South Florida

🇺🇸

Coral Gables, Florida, United States

Anderson Clinical Research

🇺🇸

San Bernardino, California, United States

DMI Helathcare Group

🇺🇸

Largo, Florida, United States

Orlando Clinical Research Center

🇺🇸

Orlando, Florida, United States

Jackson Downey, MD

🇺🇸

Jacksonville, Florida, United States

Jacksonville Center for Clinical Research

🇺🇸

Jacksonville, Florida, United States

Comprehensive NeuroScience, Inc.

🇺🇸

Sarasota, Florida, United States

Metabolic Research Institute

🇺🇸

West Palm Beach, Florida, United States

University Clinical Research

🇺🇸

Pembroke Pines, Florida, United States

nTouch Research

🇺🇸

Marietta, Georgia, United States

CSRA Partners in Health, Inc.

🇺🇸

Augusta, Georgia, United States

Physicians Research Group

🇺🇸

Indianapolis, Indiana, United States

MediSphere Medical Research Center, LLC

🇺🇸

Evansville, Indiana, United States

Androscoggin Cardiology Associates

🇺🇸

Auburn, Maine, United States

Gulf States Clinical Trails, LLC

🇺🇸

Kenner, Louisiana, United States

Phase III Clinical Research

🇺🇸

Fall River, Massachusetts, United States

Medical Research Institute

🇺🇸

Slidell, Louisiana, United States

Physician Clinical Research Service

🇺🇸

White Plains, New York, United States

JM Clinical Trials, Inc.

🇺🇸

Swansea, Massachusetts, United States

Endocrinology and Diabetes Consultants, PC

🇺🇸

Dover, New Hampshire, United States

Radiant Reseach-Moorestown

🇺🇸

Moorestown, New Jersey, United States

Center for Nutrition and Preventive Medicine

🇺🇸

Charlotte, North Carolina, United States

Medical University of South Carolina, Division of Clinical Pharmacology

🇺🇸

Charleston, South Carolina, United States

Costal Carolina Research Center

🇺🇸

Mt. Pleasant, South Carolina, United States

TriCities Medical Reseach

🇺🇸

Bristol, Tennessee, United States

Endocrine and Diabetes

🇺🇸

Ogden, Utah, United States

Diabetes $ Glandular Disease Clinic, PA

🇺🇸

San Antonio, Texas, United States

National Clinical Research

🇺🇸

Richmond, Virginia, United States

Sanofi-aventis Administrative Office

🇬🇧

Guildford Surrey, United Kingdom

Sanofi-aventis Administrative office

🇵🇱

Warszawa, Poland

Lovelace Scientific Resources

🇺🇸

Albuquerque, New Mexico, United States

Radiant Research

🇺🇸

Portland, Oregon, United States

© Copyright 2025. All Rights Reserved by MedPath